PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's financial stability and solvency. Value investors pay close attention to leverage and liquidity risk, ensuring the company has enough cushion to withstand downturns without impairing shareholder value.
No Data
No Data available this quarter, please select a different quarter.
2.39
Net debt of 2.39 while RVPH shows zero net debt. Bruce Berkowitz would look for higher returns justifying the leverage.
No Data
No Data available this quarter, please select a different quarter.
3.68
Current ratio of 3.68 while RVPH has zero ratio. Bruce Berkowitz would examine if our working capital management provides advantages.
No Data
No Data available this quarter, please select a different quarter.